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Abstract
Appropriate antibiotic use improves patient outcome and pre-
vents the emergence of antibiotic resistance. A point-prevalence
audit of antibiotic use at Beaumont Hospital, Dublin was carried
out during the collection of data for the 2006 Hospital Infection
Society (HIS) Prevalence Survey of Healthcare-Associated Infec-
tion. All inpatients who met the HIS survey entry criteria were
included in the HIS survey, and all inpatients who were receiving
antibiotics at the time of the survey were included in the point-
prevalence audit of antibiotic use. Among these, 7.18% and
36.8% of patients had a healthcare-associated infection (HCAI)
and were on antibiotics, respectively. Unnecessary collection of
duplicate data was avoided by conducting an audit of antibiotic
use and a national survey of HCAI simultaneously.
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Antibiotic stewardship includes appropriate selection, dose,
route and duration of antibiotic therapy, and has been shown
to minimize the emergence of resistance [1]. The importance
of antibiotic stewardship via comprehensive guidelines and
the development of an institutional programme has been well
described [2]. Auditing antibiotic use is essential in monitor-
ing appropriate use within an institution. Data from the
European Antimicrobial Resistance Surveillance Scheme have
repeatedly demonstrated that antibiotic resistance in the
Republic of Ireland is high as compared with other European
countries [3].
As part of the third Hospital Infection Society (HIS) Preva-
lence Survey of Healthcare-Associated Infection in the UK
and Ireland, healthcare-associated infection (HCAI) point-
prevalence surveys were carried out during 2006 in the
Republic of Ireland. The survey aims, protocol, dataset,
HCAI definitions, eligibility criteria and sampling strategies
are described elsewhere [4]. Forty-four Irish hospitals
participated in the survey, including Beaumont Hospital,
Dublin (a 720-bed tertiary-referral centre). During participa-
tion in the HIS prevalence survey, additional data were
collected concerning all inpatients at the time of the survey
who were being treated with antibiotics, regardless of the
indication for treatment (that is, patients with both HCAIs
and community-acquired infections (CAIs) were included).
Data concerning antibiotics, dosage, documentation
in medical notes, route of administration and indications
for treatment were recorded. Standardized definitions of
infection (HCAI and CAI) according to the CDC were used.
In total, 529 patients were surveyed and 38 (7.18%)
patients had an HCAI. The most common HCAIs were
respiratory tract infections (2.65%) and surgical site infec-
tions (1.7%). Ninety-one (17.2%) patients had a CAI, the
most common being respiratory tract (9.83%) and urinary
tract (1.89%) infections.
One hundred and ninety-five (36.8%) patients were
receiving 313 antibiotics, the most frequently used being cip-
rofloxacin (12.5%), co-amoxiclav (10.5%), piperacillin–tazo-
bactam (9%), and metronidazole (7.7%). Almost all (91.7%)
antibiotics had been prescribed at an appropriate dose (as
per local antibiotic formulary). The number of patients in the
various specialties who were receiving antibiotics and the
reasons for antibiotic treatment are outlined in Table 1.
One hundred and forty-eight (75.9%) antibiotics were pre-
scribed empirically; antibiotics were directed in 16 (8.2%)
patients, prophylactic in 24 (12.3%) patients, and a combina-
tion of empire and prophylactic in six (3.1%) patients. The
initial antibiotic course was continued unaltered for 152
(78%) patients, and was changed empirically for 28 (14.4%)
patients; there was a directed change for 14 (7.2%) patients.
Among the 28 patients whose antibiotics were changed
empirically, in 16 (57.1%) cases the decision was made
by the primary team, in eight (28.6%) cases by a clinical
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microbiologist, and in three (10.7%) cases after consultation
with other clinical teams; in the case of one (3.6%) patient, it
was not clear who made the decision. Directed change of
the antibiotic regimen was decided by either a clinical micro-
biologist (85.7%) or the primary team (14.3%).
Table 2 summarizes the details recorded in the medical
notes. The majority of variables examined in the medical
notes were documented between 50% and 70% of the time.
Information concerning the planned duration of antibiotic
treatment was rarely recorded; this information was docu-
mented in the medical notes or drug prescription charts of
only 6.7% of patients.
The key findings of this analysis included the following: the
nature of antibiotic prescribing is largely empirical; antibiotics
are rarely altered once commenced; ciprofloxacin is the
commonest antibiotic prescribed; and documentation of the
planned duration of antibiotic therapy is rare. The common
use of ciprofloxacin is of concern because of its reported
association with Clostridium difficile, especially strain 027.
The prevalence of HCAI in Beaumont Hospital, Dublin
was 7.18%. This compares favourably with an HCAI rate of
6% for all Irish tertiary-referral centres, given the complexity
of the patient mix in this hospital [5]. Of particular concern
was the 21.5% of patients in whom there was no apparent
indication for antibiotic treatment. This overuse of antibiotics
has many detrimental effects, including emergence of bacte-
rial resistance, rising drug costs, and adverse effects on the
individual patient.
This study highlights the fact that the majority of patients
(76.4%) initially receive antibiotics empirically, and that this
initial course continues unaltered for most patients (78%). It
is therefore essential that the initial antibiotic choice is
appropriate, is in accordance with hospital policy, and is sub-
ject to ongoing review as part of antibiotic stewardship. The
practice of documenting the planned duration of antibiotic
treatment was disappointing, at only 6.7%, as such documen-
tation prevents overprescribing. Pharmacists and medical staff
have a key role to play in improving documentation in pre-
scription charts to ensure that patients do not remain on
prolonged courses of antibiotics unnecessarily.
This study highlights a number of interesting issues related
to antibiotic stewardship, as data were collected as part of a
UK and Ireland initiative to determine the prevalence of
HCAI. A local audit of antibiotic use in conjunction with a
national survey with robust case definitions allowed a simul-
taneous audit of antibiotic use and a point-prevalence survey
concerning both HCAI and CAI, and facilitated comparisons
of the HCAI rate at Beaumont Hospital with national figures
via a national database. Although this resulted in considerable
additional data collection and analysis, a comprehensive data-
base concerning the prevalence of infection at Beaumont
Hospital, and the appropriate and inappropriate use of anti-
biotics in treating these infections, was established. We felt
that this method was superior to either an audit or a preva-
lence survey carried out separately, and gave us valuable
additional data. These data strongly suggest that antibiotic
use could be improved by taking a number of steps.
TABLE 1. The number of patients and the reasons for antibiotic use by each specialty, collected as part of the 2006 Hospital





CAI (%) HCAI (%) Prophylaxis (%) Not available (%)
Cardiology 35 11 (31.4) 5 (45.4) 1 (9.1) 4 (36.4) 1 (9.1)
General medicine 192 72 (37.5) 49 (68) 9 (12.5) 5 (6.9) 9 (12.5)
Haematology/oncology 30 20 (66.7) 4 (20) 6 (30) – 10 (50)
Nephrology 40 20 (50) 10 (50) 3 (15) 1 (5) 6 (30)
Neurology 29 4 (13.8) 4 (100) – – –
General surgery 87 39 (44.8) 10 (25.6) 8 (20.5) 8 (20.5) 13 (33.3)
Orthopaedics 26 6 (23.1) 3 (50) 2 (33.3) 1 (16.7) –
Urology 23 9 (39.1) 2 (22.2) 2 (22.2) 5 (55.5) –
Neurosurgery 64 13 (20.3) 3 (23.1) 7 (53.8) – 3 (23.1)
Dual specialitya 3 1 (33.1) 1 (100) – – –
Total 529 195 (36.8) 91 (46.6) 38 (19.4) 24 (12.3) 42 (21.5)
CAI, community-acquired infection; HCAI, healthcare-associated infection.
aPatients under the care of more than one physician/surgeon.
TABLE 2. Documentation of the indication for antibiotic
prescription and planned duration of therapy in case notes
Documentation Yes (%) No (%)
Temperature 135 (69.2) 60 (30.8)
Pulse rate 99 (50.8) 96 (49.2)
Blood pressure 106 (54.4) 89 (45.6)
White cell count 120 (61.5) 75 (38.5)
Likely source of infection 137 (70.3) 58 (29.7)
Drug name 141 (72.3) 54 (27.7)
Planned duration of use (treatment or prophylaxis) 13 (6.7) 182 (93.3)
Microbiology specimen taken 115 (59) 80 (41)
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Clearly defined antibiotic protocols to guide empirical
therapy are available but need to be reinforced via regular
education of and feedback to all doctors. An antibiotic phar-
macist has recently been appointed at Beaumont Hospital, in
accordance with a national strategy for the control of antibi-
otic resistance [6]. This individual has a key role in ensuring
compliance with antibiotic guidelines, education of medical
staff, and regular audit of antibiotic prescribing. Although
there is a significant history of antibiotic stewardship in
Beaumont Hospital [7,8], these data emphasize the need for
daily review of the need for continued antibiotic treatment
by a senior doctor (i.e. at the consultant level), a microbiolo-
gist, or an infectious disease physician.
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Abstract
Knowledge about seasonal trends in acute toxoplasmosis in
pregnancy may help to understand and avoid risk factors for
infection. Analysing regular screening records of 51 754 pregnant
women, members of the largest statutory health insurance com-
pany in the federal state of Upper Austria from 2000 to 2005,
we found a twofold increase of diagnoses of acute toxoplasmosis
during winter months. Taking the delay between infection and
screening into account, the increased number of detections in
winter points towards more frequent infections in autumn. We
propose a higher consumption of contaminated vegetables and
fruit from gardening as one of the potential explanations.
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Acute toxoplasmosis in pregnant women carries a risk of
infection for the unborn that might result in moderate to
severe ocular and neurological disorders [1]. Secondary pre-
vention using general screening during pregnancy and antimi-
crobial treatment is cumbersome, still disputed and offered
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